Background: Molecules secreted by Trypanosoma cruzi (T. cruzi) have beneficial effects on
the immune system and can fight against cancer by inhibiting the growth of tumor cells …

Circular RNA (circRNA) plays an essential role in the development and progression of
various cancers. However, the functions and mechanisms of circRNA in colorectal liver …

The presence of liver metastases drastically worsens the prognosis of cancer patients. The
liver is the second most prevalent metastatic site in cancer patients, but systemic therapeutic …

The hallmark feature of metabolic reprogramming is now considered to be widespread in
many malignancies, including colorectal cancer (CRC). Of the gastrointestinal tumors, CRC …

Metastatic colorectal cancer (CRC) is a major cause of cancer-related death, and incidence
is rising in younger populations (younger than 50 years). Current chemotherapies can …

Objectives To evaluate the use of granulocyte colony-stimulating factor (G-CSF) prophylaxis
in US patients with selected metastatic cancers and chemotherapy-induced febrile …

Simple Summary Tumor necrosis factor (TNF) and its closely related cytokine, lymphotoxin
alpha (LTα), are part of the TNF superfamily and exert their functions via both overlapping …

Colorectal cancer (CRC) belongs to the most common cancers. The liver is a predominant
site of CRC dissemination. Novel biomarkers for predicting the survival of CRC patients with …

Background Liver is the most common metastatic site of colorectal cancer (CRC) and liver
metastasis (LM) determines subsequent treatment as well as prognosis of patients …

Background and purpose While HCC is an inflammation-associated cancer, CRLM
develops on permissive healthy liver microenvironment. To evaluate the immune aspects of …